An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
for Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
46 locations incl. Scottsdale
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05667493·Phase 3·Enrolling By Invitation